Steven Litchfield sells 20,000 shares of MaxLinear (NASDAQ: MXL) in Form 144
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Steven Litchfield sold 20,000 shares of Common stock as reported on 03/04/2026. The filing shows the sale value at $349,918.00 and lists the securities sold as Restricted Stock acquired 02/20/2025.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 sale by an individual reporting a restricted‑stock disposition.
The filing records a sale of 20,000 Common shares on 03/04/2026 for $349,918.00. The securities are identified as Restricted Stock acquired on 02/20/2025.
Timing and method details beyond the sale date and value are not provided; cash‑flow counterparty is not stated in the excerpt. Subsequent filings may show the actual purchaser or method of sale.
FAQ
What did the Form 144 for MXL disclose about the transaction?
The Form 144 discloses a sale of 20,000 Common shares by Steven Litchfield on 03/04/2026. The filing reports gross disposition proceeds of $349,918.00 and identifies the securities as Restricted Stock originally acquired on 02/20/2025.
Who reported the sale in the MXL Form 144 filing?
The sale was reported by Steven Litchfield in the Form 144 submission. The form includes his address and shows the disposition of Common shares; it does not attribute the transaction to another entity or provide additional attribution language in the excerpt.
Does the Form 144 excerpt state how the sale was executed for MXL?
No—execution method and purchaser information are not provided in the excerpt. The form lists the sale date, share count, and gross proceeds, but does not specify whether sales were open‑market, block trades, or privately negotiated.